What Happened? Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 2.3% in the morning session after JPMorgan ...

Exponent (EXPO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

JP Morgan recently initiated coverage on Exponent with an Overweight/Buy rating, highlighting the firm’s position as a ...

MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025. “Exponent delivered a ...

Exponent (EXPO) recently reported third quarter earnings and revenue that came in ahead of expectations, a result that coincided with analyst upgrades and a more upbeat tone from management regarding ...

MENLO PARK, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2025 financial results for the period ended ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity ...

Engineering and scientific consulting firm Exponent Inc (NASDAQ:EXPO) shares are skyrocketing after the company reported better-than-expected first-quarter FY24 earnings. Exponent reported ...